These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12369987)

  • 21. Small-molecule inhibitors of the interaction between TNF and TNFR.
    Davis JM; Colangelo J
    Future Med Chem; 2013 Jan; 5(1):69-79. PubMed ID: 23256814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases.
    Edwards CK
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I73-81. PubMed ID: 10577978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
    Meyer O
    Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of TNF family ligands and receptors and agents which modify their interaction as therapeutic agents.
    Gardnerova M; Blanqué R; Gardner CR
    Curr Drug Targets; 2000 Dec; 1(4):327-64. PubMed ID: 11467075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor receptor pre-ligand assembly domain is an important therapeutic target in inflammatory arthritis.
    Deng GM
    BioDrugs; 2007; 21(1):23-9. PubMed ID: 17263587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural principles of tumor necrosis factor superfamily signaling.
    Vanamee ÉS; Faustman DL
    Sci Signal; 2018 Jan; 11(511):. PubMed ID: 29295955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of naphthyl-N-acylhydrazone p38α MAPK inhibitors with in vivo anti-inflammatory and anti-TNF-α activity.
    Freitas RHCN; Cordeiro NM; Carvalho PR; Alves MA; Guedes IA; Valerio TS; Dardenne LE; Lima LM; Barreiro EJ; Fernandes PD; Fraga CAM
    Chem Biol Drug Des; 2018 Feb; 91(2):391-397. PubMed ID: 28815968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model complexes of tumor necrosis factor-alpha with receptors R1 and R2.
    Fu ZQ; Harrison RW; Reed C; Wu J; Xue YN; Chen MJ; Weber IT
    Protein Eng; 1995 Dec; 8(12):1233-41. PubMed ID: 8869635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2009; 16(24):3152-67. PubMed ID: 19689289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of TNF receptor family members to inhibit autoimmune disease.
    Weinberg AD; Montler R
    Curr Drug Targets Inflamm Allergy; 2005 Apr; 4(2):195-203. PubMed ID: 15853742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of a novel and highly specific tumor necrosis factor alpha (TNFalpha) antagonist: insight from the crystal structure of the antagonist-TNFalpha complex.
    Byla P; Andersen MH; Holtet TL; Jacobsen H; Munch M; Gad HH; Thøgersen HC; Hartmann R
    J Biol Chem; 2010 Apr; 285(16):12096-100. PubMed ID: 20179326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders.
    Calamia KT
    Adv Exp Med Biol; 2003; 528():545-9. PubMed ID: 12918761
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.
    Tracey D; Klareskog L; Sasso EH; Salfeld JG; Tak PP
    Pharmacol Ther; 2008 Feb; 117(2):244-79. PubMed ID: 18155297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF alpha and the TNF receptor superfamily: structure-function relationship(s).
    Idriss HT; Naismith JH
    Microsc Res Tech; 2000 Aug; 50(3):184-95. PubMed ID: 10891884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-TNFα therapy in inflammatory lung diseases.
    Malaviya R; Laskin JD; Laskin DL
    Pharmacol Ther; 2017 Dec; 180():90-98. PubMed ID: 28642115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologics in the treatment of transplant rejection and ischemia/reperfusion injury: new applications for TNFalpha inhibitors?
    Pascher A; Klupp J
    BioDrugs; 2005; 19(4):211-31. PubMed ID: 16128605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha.
    Carter PH; Scherle PA; Muckelbauer JK; Voss ME; Liu RQ; Thompson LA; Tebben AJ; Solomon KA; Lo YC; Li Z; Strzemienski P; Yang G; Falahatpisheh N; Xu M; Wu Z; Farrow NA; Ramnarayan K; Wang J; Rideout D; Yalamoori V; Domaille P; Underwood DJ; Trzaskos JM; Friedman SM; Newton RC; Decicco CP
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):11879-84. PubMed ID: 11592999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analyses of complex formation and binding sites between human tumor necrosis factor-alpha and its three antagonists elucidate their different neutralizing mechanisms.
    Kim MS; Lee SH; Song MY; Yoo TH; Lee BK; Kim YS
    J Mol Biol; 2007 Dec; 374(5):1374-88. PubMed ID: 17996896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational design of helical peptides targeting TNFα.
    Zhang C; Shen Q; Tang B; Lai L
    Angew Chem Int Ed Engl; 2013 Oct; 52(42):11059-62. PubMed ID: 24038781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.